<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37112912</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">932</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15040932</ELocationID><Abstract><AbstractText>Coxsackievirus A10 (CVA10) causes hand, foot, and mouth disease (HFMD) and herpangina, which can result in severe neurological symptoms in children. CVA10 does not use the common enterovirus 71 (EV71) receptor, human SCARB2 (hSCARB2, scavenger receptor class B, member 2), for infection but instead uses another receptor, such as KREMEN1. Our research has shown that CVA10 can infect and replicate in mouse cells expressing human SCARB2 (3T3-SCARB2) but not in the parental NIH3T3 cells, which do not express hSCARB2 for CVA10 entry. Knocking down endogenous hSCARB2 and KREMEN1 with specific siRNAs inhibited CVA10 infection in human cells. Co-immunoprecipitation confirmed that VP1, a main capsid protein where virus receptors for attaching to the host cells, could physically interact with hSCARB2 and KREMEN1 during CVA10 infection. It is the efficient virus replication following virus attachment to its cellular receptor. It resulted in severe limb paralysis and a high mortality rate in 12-day-old transgenic mice challenged with CVA10 but not in wild-type mice of the same age. Massive amounts of CVA10 accumulated in the muscles, spinal cords, and brains of the transgenic mice. Formalin inactivated CVA10 vaccine-induced protective immunity against lethal CVA10 challenge and reduced the severity of disease and tissue viral loads. This is the first report to show that hSCARB2 serves as an associate to aid CVA10 infection. hSCARB2-transgenic mice could be useful in evaluating anti-CVA10 medications and studying the pathogenesis induced by CVA10.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Shu-Ling</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Nai-Hsiang</ForeName><Initials>NH</Initials><Identifier Source="ORCID">0000-0002-0210-6867</Identifier><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Biotechnology in Medicine, Institute of Molecular Medicine, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 300, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yu-Ching</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yi-An</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying-Chin</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Yen-Hung</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County 350, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>16VY3TM7ZO</RegistryNumber><NameOfSubstance UI="C052091">antineoplaston A10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041681" MajorTopicYN="N">NIH 3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">coxsackieviruses A10</Keyword><Keyword MajorTopicYN="N">human SCARB2</Keyword><Keyword MajorTopicYN="N">transgenic mice</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37112912</ArticleId><ArticleId IdType="pmc">PMC10144829</ArticleId><ArticleId IdType="doi">10.3390/v15040932</ArticleId><ArticleId IdType="pii">v15040932</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Itagaki A., Kamahora T., Kurimura T. Isolation and characterization of a cold-sensitive strain of coxsackievirus A10. Pt 4J. Gen. Virol. 1987;68:1191–1194. doi: 10.1099/0022-1317-68-4-1191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-68-4-1191</ArticleId><ArticleId IdType="pubmed">3033134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoa-Tran T.N., Nguyen A.T., Dao A.T.H., Kataoka C., Ta H.T.T., Nguyen H.T.V., Takemura T., Nguyen T.T.T., Vu H.M., Nguyen T.T.H., et al. Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012-2017: Endemic circulation and emergence of new HFMD-causing lineages. Arch. Virol. 2020;165:823–834. doi: 10.1007/s00705-020-04536-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-020-04536-3</ArticleId><ArticleId IdType="pubmed">32008121</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A., Henquell C., Archimbaud C., Ughetto S., Antona D., Bailly J.L., Peigue-Lafeuille H. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: A large citywide, prospective observational study. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2012;18:E110–E118.</Citation><ArticleIdList><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizasoain A., Mir D., Martinez N., Colina R. Coxsackievirus A10 causing hand-foot-and-mouth disease in Uruguay. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 2020;94:1–3. doi: 10.1016/j.ijid.2020.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.02.012</ArticleId><ArticleId IdType="pubmed">32081777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., He S., Yan Q., Xu X., Wu W., Ge S., Zhang S., Chen M., Xia N. Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 2017;93:20–24. doi: 10.1016/j.jcv.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.011</ArticleId><ArticleId IdType="pubmed">28577423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Gao F., Mao Q., Sun S., Wu X., Liu S., Yang X., Liang Z. Hand, foot, and mouth disease associated with coxsackievirus A10: More serious than it seems. Expert Rev. Anti-Infect. Ther. 2019;17:233–242.</Citation><ArticleIdList><ArticleId IdType="pubmed">30793637</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuschino M.E., Lamson D.M., Rush K., Carbone L.S., Taff M.L., Hua Z., Landi K., George K.S. Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 2012;53:259–261. doi: 10.1016/j.jcv.2011.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.011</ArticleId><ArticleId IdType="pubmed">22209288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Wang D., Yan D., Zhu S., Liu J., Wang H., Zhao S., Yu D., Nan L., An J., et al. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J. Clin. Microbiol. 2010;48:619–622. doi: 10.1128/JCM.02338-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02338-09</ArticleId><ArticleId IdType="pmc">PMC2815627</ArticleId><ArticleId IdType="pubmed">20018819</ArticleId></ArticleIdList></Reference><Reference><Citation>Munivenkatappa A., Yadav P.D., Nyayanit D.A., Majumdar T.D., Sangal L., Jain S., Sinha D.P., Shrivastava A., Mourya D.T. Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17] Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2018;66:101–110.</Citation><ArticleIdList><ArticleId IdType="pubmed">30217658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Dong Z., Li J., Carr M.J., Zhuang D., Wang J., Zhang Y., Ding S., Tong Y., Li D., et al. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection. J. Virol. 2017;91:e00333-17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469256</ArticleId><ArticleId IdType="pubmed">28424287</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhao H., Yang L., Hou W., Xu L., Wu Y., Wang W., Chen C., Wan J., Ye X., et al. A neonatal mouse model of coxsackievirus A10 infection for anti-viral evaluation. Antivir. Res. 2017;144:247–255.</Citation><ArticleIdList><ArticleId IdType="pubmed">28625478</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Yue L., Yang T., Shen D., Li H., Song X., Xie T., He X., Xie Z. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine. Biomed. Pharmacother. 2021;143:112212. doi: 10.1016/j.biopha.2021.112212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112212</ArticleId><ArticleId IdType="pubmed">34649345</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang C., Liu Q., Gong S., Geng L., Huang Z. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection. Antivir. Res. 2018;152:124–130.</Citation><ArticleIdList><ArticleId IdType="pubmed">29470994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Dong Z., Wang Q., Carr M.J., Li J., Liu T., Li D., Shi W. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice. Vaccine. 2018;36:7095–7104.</Citation><ArticleIdList><ArticleId IdType="pubmed">30316529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Xia Y., Zhu S., Xu F., Sun Y., Lu H., Gao M., Yang Z., Mao Z., Ge Q., et al. Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation. Virus Res. 2020;286:198067. doi: 10.1016/j.virusres.2020.198067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198067</ArticleId><ArticleId IdType="pubmed">32553610</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C., Liu Q., Zhou Y., Ku Z., Wang L., Lan K., Ye X., Huang Z. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge. Vaccine. 2016;34:5005–5012. doi: 10.1016/j.vaccine.2016.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.08.033</ArticleId><ArticleId IdType="pubmed">27562093</ArticleId></ArticleIdList></Reference><Reference><Citation>An H.H., Li M., Liu R.L., Wu J., Meng S.L., Guo J., Wang Z.J., Qian S.S., Shen S. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice. Emerg. Microbes Infect. 2023;12:e2147022. doi: 10.1080/22221751.2022.2147022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2147022</ArticleId><ArticleId IdType="pmc">PMC9848378</ArticleId><ArticleId IdType="pubmed">36373411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., Sun Y., Fan J., Zhu B., Cao L., Gao Q., Zhang Y., Liu H., Rao Z., Wang X. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Nat. Commun. 2018;9:4985. doi: 10.1038/s41467-018-07531-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07531-0</ArticleId><ArticleId IdType="pmc">PMC6255764</ArticleId><ArticleId IdType="pubmed">30478256</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J., van den Hengel L.G., Raaben M., Blomen V.A., Carette J.E., Brummelkamp T.R. KREMEN1 Is a Host Entry Receptor for a Major Group of Enteroviruses. Cell Host Microbe. 2018;23:636–643.e5. doi: 10.1016/j.chom.2018.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.03.019</ArticleId><ArticleId IdType="pubmed">29681460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao B., Wu W., Davidson G., Marhold J., Li M., Mechler B.M., Delius H., Hoppe D., Stannek P., Walter C., et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 2002;417:664–667. doi: 10.1038/nature756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature756</ArticleId><ArticleId IdType="pubmed">12050670</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimizu H. Cellular receptors for human enterovirus species a. Front. Microbiol. 2012;3:105. doi: 10.3389/fmicb.2012.00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00105</ArticleId><ArticleId IdType="pmc">PMC3313065</ArticleId><ArticleId IdType="pubmed">22470371</ArticleId></ArticleIdList></Reference><Reference><Citation>de Villiers W.J., Smart E.J. Macrophage scavenger receptors and foam cell formation. J. Leukoc. Biol. 1999;66:740–746. doi: 10.1002/jlb.66.5.740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.66.5.740</ArticleId><ArticleId IdType="pubmed">10577503</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskelinen E.L., Tanaka Y., Saftig P. At the acidic edge: Emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003;13:137–145.</Citation><ArticleIdList><ArticleId IdType="pubmed">12628346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798–801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Yu S.L., Shao H.Y., Lin H.Y., Liu C.C., Hsiao K.N., Chitra E., Tsou Y.L., Chang H.W., Sia C., et al. Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71. PLoS ONE. 2013;8:e57591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Lin H.Y., Tsou Y.L., Chitra E., Hsiao K.N., Shao H.Y., Liu C.C., Sia C., Chong P., Chow Y.H. Human SCARB2-mediated entry and endocytosis of EV71. PLoS ONE. 2012;7:e30507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.C., Chou A.H., Lien S.P., Lin H.Y., Liu S.J., Chang J.Y., Guo M.S., Chow Y.H., Yang W.S., Chang K.H., et al. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine. 2011;29:4362–4372.</Citation><ArticleIdList><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dun Y., Yan J., Wang M., Wang M., Liu L., Yu R., Zhang S. Rac1-dependent endocytosis and Rab5-dependent intracellular trafficking are required by Enterovirus A71 and Coxsackievirus A10 to establish infections. Biochem. Biophys. Res. Commun. 2020;529:97–103.</Citation><ArticleIdList><ArticleId IdType="pubmed">32560826</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E.G., Perez-Nunez D., Revilla Y. Mechanisms of Entry and Endosomal Pathway of African Swine Fever Virus. Vaccines. 2017;5:42. doi: 10.3390/vaccines5040042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines5040042</ArticleId><ArticleId IdType="pmc">PMC5748609</ArticleId><ArticleId IdType="pubmed">29117102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai R.H., Chow Y.H., Chung N.H., Chen T.C., Shie F.S., Juang J.L. Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling. Cell Death Dis. 2022;13:328. doi: 10.1038/s41419-022-04771-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04771-3</ArticleId><ArticleId IdType="pmc">PMC8995170</ArticleId><ArticleId IdType="pubmed">35399111</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.W., Lin Y.W., Ho H.M., Lin M.H., Liu C.C., Shao H.Y., Chong P., Sia C., Chow Y.H. Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS ONE. 2013;8:e69858. doi: 10.1371/journal.pone.0069858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069858</ArticleId><ArticleId IdType="pmc">PMC3728341</ArticleId><ArticleId IdType="pubmed">23936115</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou Y.L., Lin Y.W., Shao H.Y., Yu S.L., Wu S.R., Lin H.Y., Liu C.C., Huang C., Chong P., Chow Y.H. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl. Trop. Dis. 2015;9:e0003692. doi: 10.1371/journal.pntd.0003692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003692</ArticleId><ArticleId IdType="pmc">PMC4391779</ArticleId><ArticleId IdType="pubmed">25855976</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Cai J., Ge Y., Wang C., Qiu Y., Xia A., Zeng M. Non-polio enterovirus infections in children with central nervous system disorders in Shanghai, 2016-2018: Serotypes and clinical characteristics. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 2020;129:104516. doi: 10.1016/j.jcv.2020.104516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104516</ArticleId><ArticleId IdType="pubmed">32585621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G., Carr M.J., Kobayashi M., Hanaoka N., Fujimoto T. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World. Int. J. Mol. Sci. 2019;20:5201. doi: 10.3390/ijms20205201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205201</ArticleId><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>